Omeros (OMER) Net Income towards Common Stockholders (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.67% |
| Dec 31, 2025 | 167.82% |
| Sep 30, 2025 | -2,175.97% |
| Jun 30, 2025 | -88.65% |
| Mar 31, 2025 | -20.80% |
| Dec 31, 2024 | 6.19% |
| Sep 30, 2024 | -46.27% |
| Jun 30, 2024 | 36.27% |
| Mar 31, 2024 | -77.94% |
| Dec 31, 2023 | 117.31% |
| Sep 30, 2023 | 98.66% |
| Jun 30, 2023 | 17.02% |
| Mar 31, 2023 | -96.58% |
| Dec 31, 2022 | 368.13% |
| Sep 30, 2022 | 244.24% |
| Jun 30, 2022 | 67.30% |
| Mar 31, 2022 | -98.02% |
| Dec 31, 2021 | 1,419.97% |
| Sep 30, 2021 | -0.09% |
| Jun 30, 2021 | 47.11% |
| Mar 31, 2021 | 120.30% |
| Dec 31, 2020 | -87.98% |
| Sep 30, 2020 | -14.28% |
| Jun 30, 2020 | -13.79% |
| Mar 31, 2020 | 73.56% |
| Dec 31, 2019 | -579.59% |
| Sep 30, 2019 | -10.73% |
| Jun 30, 2019 | 40.14% |
| Mar 31, 2019 | -5.15% |
| Dec 31, 2018 | 41.01% |
| Sep 30, 2018 | -16.77% |
| Jun 30, 2018 | -12.38% |
| Mar 31, 2018 | -79.65% |
| Dec 31, 2017 | -115.27% |
| Sep 30, 2017 | 46.19% |
| Jun 30, 2017 | 4.72% |
| Mar 31, 2017 | -7.54% |
| Dec 31, 2016 | -0.96% |
| Sep 30, 2016 | -10.85% |
| Jun 30, 2016 | 38.61% |
| Mar 31, 2016 | -10.50% |
| Dec 31, 2015 | 6.56% |
| Sep 30, 2015 | -19.33% |
| Jun 30, 2015 | 10.50% |
| Mar 31, 2015 | 10.47% |
| Dec 31, 2014 | -16.72% |
| Sep 30, 2014 | 0.43% |
| Jun 30, 2014 | -10.99% |
| Mar 31, 2014 | -17.45% |
| Dec 31, 2013 | 0.71% |
| Sep 30, 2013 | -2.01% |
| Jun 30, 2013 | -29.68% |
| Mar 31, 2013 | -34.29% |
| Dec 31, 2012 | 41.24% |
| Sep 30, 2012 | -54.59% |
| Jun 30, 2012 | -1.60% |
| Mar 31, 2012 | 17.53% |
| Dec 31, 2011 | -55.20% |
| Sep 30, 2011 | -22.35% |
| Jun 30, 2011 | 18.79% |
| Mar 31, 2011 | 23.98% |
| Dec 31, 2010 | -14.26% |
| Sep 30, 2010 | 3.47% |